Company intelligence / Profile preview
Bilthoven Biologicals
- Ownership
- Private
- Employees
- ~500
- Development stage
- Commercial
Overview
Bilthoven Biologicals produces and supplies commercial-stage vaccines including inactivated polio vaccine, diphtheria-tetanus-polio combination vaccines, tetanus vaccines, and BCG for bladder cancer. Their products are distributed globally through organizations like UNICEF to support disease eradication efforts such as polio elimination.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- VaccineBiologicRecombinant protein
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Bilthoven Biologicals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bilthoven Biologicals.